{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-22-019046","form_type":"8-K","ticker":"AYTU","cik":"0001385818","company_name":"AYTU BIOPHARMA, INC","filed_at":"2022-12-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.401672+00:00","generated_at":"2026-06-20T21:23:00.081312+00:00","sec_items":["8.01","9.01","99.1"],"event_type":"litigation","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Aytu settles derivative lawsuits over 2021 option grants; cancels 25% of awards, adds independent directors","bullets":["Settlement cancels 387,804 of 1,551,216 shares (25%) from 2021 option grants to directors and officers.","Company to add two independent directors within six months; one appointed as Compensation Committee chair.","Non-employee director compensation capped at $175,000 annually through 2024; new equity plan with reserve ≤15% of outstanding.","No further equity awards to defendants under 2015 plan; lead independent director to be designated.","Aytu to pay up to $425,000 in attorneys' fees; no admission of wrongdoing."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-22-019046","json":"https://secwatch.observer/filing/0001558370-22-019046.json","markdown":"https://secwatch.observer/filing/0001558370-22-019046.md","text":"https://secwatch.observer/filing/0001558370-22-019046.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1385818/000155837022019046/0001558370-22-019046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1385818/000155837022019046/aytu-20221228x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:23:00.081312+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}